Day One
- Nadia Moodie - Portfolio Manager, LSX
- Betsabeh Madani-Hermann - Global Head of Research, Philips
- How do we accelerate digital whilst ensuring an excellent standard of care?
- Narrowing the digital divide and not leaving out large populations
- Designing digital health products that promote health equity
- Mark Davies - Chief Health Officer, IBM
- Beth Wolff - Director Digital Health Solutions, Global Corporate Strategy & BD, Lundbeck
- Emre Ozcan - Global Head of Digital Health & Devices, Merck
- What progress has been made and what are the persisting gaps/challenges in care, research, and investment?
- Highlighting successful initiatives, innovative approaches and tech solutions that have improved women's health outcomes
- Scaling up for impact - collaboration, partnerships, and sustainable funding models
- Looking to the future - What else can we do as an industry to close the gaps and create a more equitable future for women’s health?
- Esther Reynal de St Michel Richardot - Founding General Partner, THENA Capital
- Anna Klepchukova - Chief Medical Officer, Flo Health
- Eleonora Benhar - VP of Science & Data, Natural Cycles
- What is hindering us from scaling digital health beyond the first generation?
- Evaluation of the current reimbursement frameworks (France, Germany, UK)
- Insight from companies who have gone through the approval processes
- Once reimbursement has been achieved, how do you get people to buy your product/ solution?
- Hannes Klöpper - CEO, HelloBetter
- Florian Koerber - Head of Startup Relations and M&A, Flying Health
- Fiona Costello - SVP Partnerships, Brain+
- Evaluating the effectiveness of the VC funding model for digital health startups
- How do alternative funding models measure up? (grants, crowdfunding, and corporate venture capital)
- Dealing with the pressure to achieve rapid growth/ profitability and the challenges facing digital health startups
- Robert Garber - Managing Partner, 7wire Ventures
- Samana Brannigan - Head of Health Technologies, Innovate UK
- Abigail Bolton - HealthTech Venture Capital, Optum Ventures
What does it really take to have a successful partnership with pharma? The road may be long, with many twists, turns and hurdles but the ending.. worth it?
An interactive session with startups and pharma execs who have had successful partnerships. Our experts will share their experiences and provide valuable advice on navigating the complexities of a partnership with pharma, negotiating favourable terms, and maximizing the benefits of such collaborations. Most importantly, this is an opportunity to ask our expert panel burning questions you have.
- John Drakenberg - Founder & CEO, Alex Therapeutics
- Farnaz Behroozi - Head of Pharma, Huma
- David Benshoof Klein - Founder & CEO, Click Therapeutics
- Nipun Jain - Head of Innovation Hubs & Partnerships for International, AstraZeneca
The best partnerships are built on trust, knowledge-sharing, and co-creating mutually beneficial opportunities. As a digital health startup looking to scale, one of the hardest decisions is deciding who to partner with. Hear from our experts on identifying the right partner, assessing potential partners' strategic fit, building trust and collaboration, negotiating agreements and addressing common pitfalls and strategies for sustaining successful partnerships over time.
- Katariina Kronholm - Senior Commercial Director, Elekta
- Yahel Halamish - Investment Principal, Head of Investor Relations, D&I, Nina Capital
- Regina Hodits - Managing Partner, Wellington Partners
A thought-provoking debate with key leaders in the industry exploring the challenges and opportunities of scaling digital health solutions and achieving profitability. Despite significant advancements in technology, digital health has yet to fully realize its potential. This debate will delve into the key barriers hindering its widespread adoption, such as regulatory/reimbursement hurdles, privacy concerns, and technological limitations. Additionally, we will discuss the necessary conditions for digital health to succeed, including increased investment, policy changes, and a focus on patient-centred care.
- Mike Trenell - CEO & Co-Founder, Daiser
- Damien Marmion - Former Health Insurance Leader, Independent
- Jane Dacre - Emeritus Professor of Medical Education, UCL
- Stephen Ranjan - Global Head of Digital Health, Roche
- Pritesh Mistry - Fellow (Digital Technologies), The King's Fund
- Keys to success as a digital health startup when looking to expand into new markets
- Scaling in Europe vs scaling in the US
- Evaluating funding availability, investor preferences, and market size in Europe and the US
- Going to the US can be seen as the “easier” option – what’s the truth in this? What are the challenges of entering the US market?
- How can Pharma & VC’s help with geographic expansion?
- Pablo Prieto - Managing Director, CG Health Ventures
- Erki Mölder - Managing Partner, Verge Healthtech Fund
- Guillem Masferrer - Partner, Asabys Partners